Comprehensive Cancer Tumor Profiling Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

Which drivers are expected to have the greatest impact on the over the cancer tumor profiling market's growth?
The surge in global cancer occurrences is anticipated to stimulate the expansion of the cancer and tumor profiling market. Cancer is an illness characterized by abnormal cell growth that uncontrollably enlarges and invades other body parts. As cancer instances escalate, the necessity for cancer tumor profiling also heightens, supporting physicians in evaluating disease severity. For example, the American Cancer Society revealed in 2024 that the new cancer diagnoses in the US rose to 2 million, a substantial increase from 1.9 million the previous year. Consequently, the escalating global cancer occurrences contribute to the development of the cancer and tumor profiling market.

Get Your Cancer Tumor Profiling Market Report Here:
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

What is the future CAGR of the cancer tumor profiling market, and how will it impact industry expansion?
In recent times, the market size for cancer tumor profiling has seen a substantial surge. It is projected to expand from $13 billion in 2024 to $14.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.3%. This growth in the historic aspect can be credited to a rise in cancer cases, growth in the field of precision medicine initiatives and research collaborations, advancements in cancer diagnostics and its early detection methods, a broader spectrum of targeted therapy options, and robust regulatory structures backing cancer profiling tests.

The market size for cancer tumor profiling is projected to experience significant expansion in the upcoming years, with an estimate to reach $25.33 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 14.0%. This predicted growth during the forecast period is primarily due to the broadening of immunotherapy and immunoprofiling in cancer treatments, advances in liquid biopsy and non-invasive tumor profiling techniques, the utilization of single-cell sequencing for comprehensive tumor examination, the augmentation of cancer screening and early discovery initiatives, and the surging need for profiling of rare and orphan cancer subtypes. Notable trends for the forecast period encompass the incorporation of tumor profiling into standard clinical practices, advancements in multi-omics methodologies, the integration of artificial intelligence (AI) and machine learning for data interpretation, personalized medical treatments and targeted therapy evolution, and progress in genomics and next-generation sequencing (NGS) technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What are the most significant trends transforming the cancer tumor profiling market today?
The rise in research and development activities is proving to be a central trend in the cancer and tumor profiling market. Key players in this sector are concentrating their efforts on R&D to cater to patient needs and consolidate their market standing. A case in point is QIAGEN N.V, a German entity that specializes in sample and assay technology used in applied testing, the development of pharmaceuticals, molecular diagnostics and academic research. The company recently announced the CE-marked and commercial distribution of its therascreen PIK3CA RGQ PCR Kit in Europe, a tool designed to detect PIK3CA mutations in breast cancer patients. The therascreen PIK3CA test is a diagnostic tool for locating an activating mutation in the phosphatidyl 3-kinase catalytic subunit alpha (PIK3CA) gene, and it is the first to allow for the testing of both DNA from plasma specimens or FFPE tissue.

Which key market segments comprise the cancer tumor profiling market and drive its revenue growth?
The cancer tumor profiling market covered in this report is segmented -

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies
3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types
4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:
1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer
3) By Colorectal Cancer: Colon Cancer, Rectal Cancer
4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer
5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma
6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer
7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)
8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors
9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer
10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053

What regions are at the forefront of cancer tumor profiling market expansion?
North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the leading players fueling growth in the cancer tumor profiling market?
Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=6053&type=smp

What Is Covered In The Cancer Tumor Profiling Global Market Report?

•Market Size Forecast: Examine the cancer tumor profiling market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the cancer tumor profiling market for a structured understanding.
•Key Players Overview: Analyze major players in the cancer tumor profiling market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cancer tumor profiling market.
•Segment Contributions: Evaluate how different segments drive overall growth in the cancer tumor profiling market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cancer tumor profiling market.
•Industry Challenges: Identify potential risks and obstacles affecting the cancer tumor profiling market.
•Competitive Landscape: Review strategic developments in the cancer tumor profiling market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.